Usefulness and Limitation of Estrogen Receptor Protein (ERP) Assay in Human Renal Cell Carcinomas

Abstract
The presence of estrogen-binding sites in human renal cell carcinomas was demonstrated. The clinical contributions which may be obtained from this finding were analyzed. The possibility of using the ERP assay for screening of patients with estrogen-dependent tumors was discussed.

This publication has 0 references indexed in Scilit: